Business Standard

Top headlines: Moody's upgrades TaMo outlook; Sputnik V launched in India

Business Standard brings you stories that made the headlines on Friday

Sputnik V, Dr Reddy’s Laboratories, DRL, coronavirus, vaccine, covid-19
Premium

Sputnik V vaccine

BS Web Team New Delhi
Dr Reddy's launches Sputnik V vaccine in India
 
Drug firm Dr Reddy's Laboratories on Friday said it has launched COVID vaccine Sputnik V in the Indian market with the first dose being administered in Hyderabad, as part of a limited pilot. The company said the imported doses of the vaccine are presently priced at a maximum retail price of Rs 948, with 5 per cent GST per dose, amounting to Rs 995.4 per dose. READ MORE...

Moody’s upgrades outlook on Tata Motors
 
Credit rating agency, Moody's Investors Service, has upgraded its outlook on Tata Motors to stable

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in